Invitation Only Virtual Investor Conference To Be Held October 21, 2020
Speakers Include Regulatory Experts Dr. Daniel Fabricant
Sponsored by Jefferies, Oppenheimer & Co. and ThinkEquity
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, announced today that in conjunction with the Natural Products Association (NPA), with the goal to better clarify the landscape for investors, is launching an invitation only virtual investor conference entitled “Regulatory Roadmap For The CBD Industry”, which will focus on discussing the current regulatory climate in the CBD industry.
The conference will be moderated by Lance Blundell, Esq. Counsel for cbdMD, alongside Owen Bennett from Jefferies, Rupesh Parikh from Oppenheimer & Co. and Ashok Kumar from ThinkEquity. Moderators will have an opportunity to participate in a Q&A with Dr. Daniel Fabricant, CEO of the NPA. Participants will be invitation only at the request of the sponsors.
“The CBD industry is at an important stage in its development. Understanding the future regulatory climate is critical for CBD executives and their investors. Dr. Fabricant has a unique perspective on the future regulatory landscape and cbdMD is pleased to partner with the NPA to educate consumers, investors and distributors in this unique format,” said Mr. Blundell.
The NPA has been the leader in asking the FDA to regulate CBD since 2017, has testified on a number of occasions and has held several meetings with top FDA officials on the issue. NPA also helped craft legislation passed by the US House of Representatives that provides resources so that the FDA can perform a Health Hazard Evaluation (HHE) and set a safe level of CBD for consumers to use each day. The process would follow the same precedent as red yeast rice, which allows a natural product to contain a level of a drug ingredient that the FDA has determined to be safe.
The conference will start on Wednesday, October 21, 2020, at 10:00 am. Invitation only requests can be made through: Jefferies, Oppenheimer & Co. and ThinkEquity. A transcript of the conference will be made available to the public on October 26, 2020.
About the National Products Association (NPA)
Natural Products Association
The Natural Products Association (NPA) is the trade association representing the entire natural products industry. We advocate for our members who supply, manufacture and sell natural ingredients or products for consumers. The Natural Products Association promotes good manufacturing practices as part of the growth and success of the industry. Founded in 1936, NPA represents over 700 members accounting for more than 10,000 locations of retailers, manufacturers, wholesalers and distributors of natural products, including foods, dietary supplements, and health/beauty aids. Visit www.npanational.org .
Daniel Fabricant, Ph.D. is CEO and President of the Natural Products Association (NPA), the nation’s largest and oldest trade organization representing the natural products industry, including dietary supplements, foods, personal care products and more. Most recently, Dr. Fabricant served as the Director of the Division of Dietary Supplement Programs at the U.S. Food and Drug Administration (FDA), where he directed agency policy, public affairs and regulatory action regarding regulation of the dietary supplement industry for more than three years. While with the agency, he successfully navigated the large, heavily-matrixed government organizational structure to bring life to a regulatory function that was non-existent for almost 20 years. Dr. Fabricant carried his interest in natural products into the classroom, earning a Ph.D. in Pharmacognosy from the University of Illinois at Chicago, where he has served as an adjunct professor in the Department of Medicinal Chemistry and Pharmacognosy since 2009. He has also published extensively and is internationally recognized for his regulatory and governmental public health expertise and natural products research.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, Non-THC 1 CBD products, please visit www.cbdMD.com , follow cbdMD on Instagram and Facebook , or visit one of the 6,000 retail outlets that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2019 and Part II, Item 1A. Risk Factors appearing in its Quarterly Report on Form 10-Q for the period ended June 30, 2020, both as filed with the Securities and Exchange Commission (the "SEC") and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
1 Non-THC is defined as below the level of detection using validated scientific analytical tools.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200924005137/en/
PR :
cbdMD, Inc.
Lauren Greene
Communications Specialist
Lauren.Greene@cbdMD.com
(843) 743-9999
Investors :
cbdMD, Inc.
John Weston
Director of Investor Relations
John.Weston@cbdMD.com
(704) 249-9515